{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:57:20Z","timestamp":1793393840931,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007197","name":"u.s. public health service","doi-asserted-by":"publisher","award":["P30CA006927"],"award-info":[{"award-number":["P30CA006927"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"name":"marlyn fein chapter, fox chase board of associates","award":["(Private Funding)"],"award-info":[{"award-number":["(Private Funding)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10549-021-06460-9","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T19:03:06Z","timestamp":1641841386000},"page":"513-522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A tool to predict disparities in the timeliness of surgical treatment for breast cancer patients in the USA"],"prefix":"10.1007","volume":"191","author":[{"given":"Christopher G.","family":"Verdone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Bayron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihsiung E.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin R.","family":"Sigurdson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison A.","family":"Aggon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Porpiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen V.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary T.","family":"Pronovost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7343-932X","authenticated-orcid":false,"given":"Richard J.","family":"Bleicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"issue":"3","key":"6460_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jamaoncol.2015.4508","volume":"2","author":"RJ Bleicher","year":"2016","unstructured":"Bleicher RJ et al (2016) Time to surgery and breast cancer survival in the United States. JAMA Oncol 2(3):330\u2013339","journal-title":"JAMA Oncol"},{"issue":"3","key":"6460_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10549-019-05340-7","volume":"177","author":"SS Coughlin","year":"2019","unstructured":"Coughlin SS (2019) Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat 177(3):537\u2013548","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"6460_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jamasurg.2013.1680","volume":"148","author":"EC Smith","year":"2013","unstructured":"Smith EC, Ziogas A, Anton-Culver H (2013) Delay in surgical treatment and survival after breast cancer diagnosis in young women by race\/ethnicity. JAMA Surg 148(6):516\u2013523","journal-title":"JAMA Surg"},{"issue":"3","key":"6460_CR4","doi-asserted-by":"publisher","first-page":"e185113","DOI":"10.1001\/jamasurg.2018.5113","volume":"154","author":"YL Eaglehouse","year":"2019","unstructured":"Eaglehouse YL et al (2019) Racial differences in time to breast cancer surgery and overall survival in the US military health system. JAMA Surg 154(3):e185113","journal-title":"JAMA Surg"},{"issue":"2","key":"6460_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2014.17322","volume":"313","author":"J Iqbal","year":"2015","unstructured":"Iqbal J et al (2015) Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA 313(2):165\u2013173","journal-title":"JAMA"},{"issue":"22","key":"6460_CR6","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1002\/cncr.32378","volume":"125","author":"KE Reeder-Hayes","year":"2019","unstructured":"Reeder-Hayes KE et al (2019) Race and delays in breast cancer treatment across the care continuum in the Carolina breast cancer study. Cancer 125(22):3985\u20133992","journal-title":"Cancer"},{"key":"6460_CR7","unstructured":"National Cancer Database Tools 2021 (2021). https:\/\/www.facs.org\/quality-programs\/cancer\/ncdb. Accessed 19 Sep 2021"},{"key":"6460_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fpubh.2019.00018","volume":"7","author":"F Hossain","year":"2019","unstructured":"Hossain F et al (2019) Neighborhood social determinants of triple negative breast cancer. Front Public Health 7:18","journal-title":"Front Public Health"},{"issue":"1","key":"6460_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10549-017-4300-y","volume":"165","author":"ME Roseland","year":"2017","unstructured":"Roseland ME et al (2017) Influence of clinical, societal, and treatment variables on racial differences in ER-\/PR- breast cancer survival. Breast Cancer Res Treat 165(1):163\u2013168","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"6460_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1001\/jamasurg.2017.0005","volume":"152","author":"LA Newman","year":"2017","unstructured":"Newman LA, Kaljee LM (2017) Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg 152(5):485\u2013493","journal-title":"JAMA Surg"},{"issue":"2","key":"6460_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11524-017-0142-5","volume":"94","author":"PB DeGuzman","year":"2017","unstructured":"DeGuzman PB et al (2017) Impact of urban neighborhood disadvantage on late stage breast cancer diagnosis in Virginia. J Urban Health 94(2):199\u2013210","journal-title":"J Urban Health"},{"issue":"10","key":"6460_CR12","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1245\/s10434-016-5486-7","volume":"23","author":"AC Polverini","year":"2016","unstructured":"Polverini AC et al (2016) Time to treatment: measuring quality breast cancer care. Ann Surg Oncol 23(10):3392\u20133402","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"6460_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10549-018-5046-x","volume":"173","author":"RJ Bleicher","year":"2019","unstructured":"Bleicher RJ et al (2019) Treatment delays from transfers of care and their impact on breast cancer quality measures. Breast Cancer Res Treat 173(3):603\u2013617","journal-title":"Breast Cancer Res Treat"},{"issue":"36","key":"6460_CR14","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1200\/JCO.2012.41.7972","volume":"30","author":"RJ Bleicher","year":"2012","unstructured":"Bleicher RJ et al (2012) Preoperative delays in the US medicare population with breast cancer. J Clin Oncol 30(36):4485\u20134492","journal-title":"J Clin Oncol"},{"issue":"10","key":"6460_CR15","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1245\/s10434-018-6615-2","volume":"25","author":"RJ Bleicher","year":"2018","unstructured":"Bleicher RJ (2018) Timing and delays in breast cancer evaluation and treatment. Ann Surg Oncol 25(10):2829\u20132838","journal-title":"Ann Surg Oncol"},{"key":"6460_CR16","unstructured":"National Accreditation Program For Breast Centers Standards Manual. NAPBC Standards and Resources 2018. https:\/\/accreditation.facs.org\/accreditationdocuments\/NAPBC\/Portal%20Resources\/2018NAPBCStandardsManual.pdf. Accessed 7 Feb 2021"},{"key":"6460_CR17","unstructured":"Committee, C.o.C.Q.I. (2019) Commission on cancer quality measures. https:\/\/www.facs.org\/-\/media\/files\/qualityprograms\/cancer\/ncdb\/quality-measures.ashx. Accessed 9 July 2021"},{"issue":"2","key":"6460_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jamcollsurg.2009.04.010","volume":"209","author":"RJ Bleicher","year":"2009","unstructured":"Bleicher RJ et al (2009) Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 209(2):180\u20137 (quiz 294\u20135)","journal-title":"J Am Coll Surg"},{"issue":"4","key":"6460_CR19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.surg.2010.07.012","volume":"148","author":"M Hulvat","year":"2010","unstructured":"Hulvat M et al (2010) Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging. Surgery 148(4):746\u201350 (discussion 750\u20131)","journal-title":"Surgery"},{"issue":"1","key":"6460_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11524-007-9228-9","volume":"85","author":"JM Ferrante","year":"2008","unstructured":"Ferrante JM, Chen PH, Kim S (2008) The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health 85(1):114\u2013124","journal-title":"J Urban Health"},{"issue":"3","key":"6460_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10549-020-05644-z","volume":"181","author":"JR Dietz","year":"2020","unstructured":"Dietz JR et al (2020) Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat 181(3):487\u2013497","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06460-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-021-06460-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06460-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:42:21Z","timestamp":1744098141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-021-06460-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["6460"],"URL":"https:\/\/doi.org\/10.1007\/s10549-021-06460-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"28 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"At the time of NCDB approval, the Fox Chase Cancer Center IRB deemed NCDB studies as exempt due to their de-identification.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No patient consent to participate was required as study was performed on the NCDB databank after approval from the American College of Surgeons.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}